Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
Submitted by
admin
on December 2, 2016 - 11:27am
Source:
Medical Marketing and Media
News Tags:
Mylan Labs
EpiPens
drug pricing
Heather Bresch
Pharma CEOs
Headline:
Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
Do Not Allow Advertisers to Use My Personal information
